Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019
Open accessThe DOI matches its Crossref record; 193 of the 195 references it cites were found in a registry or an index.
Abstract
Main Recommendations: Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric adenocarcinoma. This underscores the importance of diagnosis and risk stratification for these patients. High definition endoscopy with chromoendoscopy (CE) is better than high definition white-light endoscopy alone for this purpose. Virtual CE can guide biopsies for staging atrophic and metaplastic changes and can target neoplastic lesions. Biopsies should be taken from at least two topographic sites (antrum and corpus) and labelled in two separate vials. For patients with mild to moderate atrophy restricted to the antrum there is no evidence to recommend surveillance. In patients with IM at a single location but with a family history of gastric cancer, incomplete IM, or persistent Helicobacter pylori gastritis, endoscopic surveillance with CE and guided biopsies may be considered in 3 years. Patients with advanced stages of atrophic gastritis should be followed up with a high quality endoscopy every 3 years. In patients with dysplasia, in the absence of an endoscopically defined lesion, immediate high quality endoscopic reassessment with CE is recommended. Patients with an endoscopically visible lesion harboring low or high grade dysplasia or carcinoma should undergo staging and treatment. H. pylori eradication heals nonatrophic chronic gastritis, may lead to regression of atrophic gastritis, and reduces the risk of gastric cancer in patients with these conditions, and it is recommended. H. pylori eradication is also recommended for patients with neoplasia after endoscopic therapy. In intermediate to high risk regions, identification and surveillance of patients with precancerous gastric conditions is cost-effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Both OLGA and OLGIM are advocated by international guidelines for risk stratification of individuals diagnosed with precancerous gastric mucosal changes38,39”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“The current European Society for Gastrointestinal Endoscopy guidelines advocate performing surveillance endoscopy at 3–5 years in patients with AIG.38”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“Gastric cancer is still a major world problem, ranking fifth for incidence and third for cancer-related mortality worldwide in the latest published global cancer statistics [1].”
BackgroundGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Correa, P. (1992) · PubMed · Cited by 3,216
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Self-citationInterleukin-1 polymorphisms associated with increased risk of gastric cancer
El-Omar, E. M., Carrington, M., Chow, W.-H., McColl, K. E. L., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C.-C., Rothman, N., et al. (2000) · Nature · doi:10.1038/35006081 · Cited by 2,366
(2003) · Quality and Safety in Health Care · doi:10.1136/qhc.12.1.18 · Cited by 1,446
Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Pimentel-Nunes, P., Dinis-Ribeiro, M., Ponchon, T., Repici, A., Vieth, M., De Ceglie, A., Amato, A., Berr, F., Bhandari, P., Bialek, A., et al. (2015) · Endoscopy · doi:10.1055/s-0034-1392882 · Cited by 1,329
Self-citation
Research works printed but not linked: 7
- Dinis-Ribeiro M, Areia M, de Vries AC et al. Management of precan- cerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012; 460: 19 -46
- Laurèn P. The two histological main types of gastric carcinoma: dif- fuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31 -49
- Lash JG, Genta RM. Adherence to the Sydney System guidelines in- creases the detection of Helicobacter gastritis and intestinal meta- plasia in 400738 sets of gastric biopsies. Aliment Pharmacol Ther 2013; 38: 424 -431
- Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to hu- mans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1 -241
- Matsukura N, Onda M, Tokunaga A et al. Mucosal IgA antibody against Helicobacter pylori in chronic gastritis and intestinal meta- plasia detected by the Tes-Tape method in resection specimens after gastrectomy for gastric cancer. Cancer 1995; 75: 1472 -1477
- Malfertheiner P, Megraud F, O'Morain CA et al. Management of Heli- cobacter pylori infection -the Maastricht V/Florence Consensus Re- port. Gut 2017; 66: 6 -30
- Tian W, Zhao Y, Liu S et al. Meta-analysis on the relationship be- tween nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev 2010; 19: 288 -298
Cited by
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Self-citationMalfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Pimentel-Nunes, P., Libânio, D., Bastiaansen, B. A. J., Bhandari, P., Bisschops, R., Bourke, M. J., Esposito, G., Lemmers, A., Maselli, R., Messmann, H., et al. (2022) · Endoscopy · doi:10.1055/a-1811-7025 · Cited by 808
Self-citationAGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
“The current European Society for Gastrointestinal Endoscopy guidelines advocate performing surveillance endoscopy at 3–5 years in patientswith AIG.(38) In patients with PA, observational studies suggest that the risk of gastric adenocarcinoma might be highest within the first year of diagnosis.”
BackgroundInfluentialSelf-citationLiou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322368 · Cited by 493
Metadata
- Authors
- Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., Annibale, B., Dumonceau, J.-M., Barros, R., Fléjou, J.-F., Carneiro, F., van Hooft, J., Kuipers, E., & Dinis-Ribeiro, M.
- Affiliations
- Gastroenterology Department, Portuguese Oncology Institute of Porto, Portugal
- Universidade do Porto (PT)
- Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal
- Instituto Português de Oncologia de Coimbra Francisco Gentil (PT)
- Institute of Clinical and Preventive Medicine, University of Latvia, Digestive Diseases Center, GASTRO, Riga, Latvia
- Azienda Ospedaliera Sant'Andrea (IT)
- Department of Gastroenterology, Porto University Hospital Centre, Institute of Biomedical Sciences, University of Porto (ICBAS/UP), Portugal
- INSERM U1053, Université de Bordeaux and CHU Pellegrin, Laboratoire de Bacteriologie, Bordeaux, France
- IMAD, Hepato-Gastroenterology and Digestive Oncology, CHU de Nantes, University of Nantes, France
- Gastroenterología Diagnóstica Terapeútica (AR)
- Sorbonne Université (FR)
- Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, The Netherlands
- Erasmus MC (NL)
- ORCID
- Venue
- Endoscopy
- Publisher
- Georg Thieme Verlag KG
- Published
- 2019-03-06
- Volume
- 51
- Issue
- 04
- Pages
- 365-388
- ISSN
- 0013-726X (ISSN-L)
- 1438-8812
- OpenAlex
- W2921353582
- Cited by
- 993
- References
- 195
- Citations by year
- 2026: 82 · 2025: 126 · 2024: 165 · 2023: 159 · 2022: 153 · 2021: 136 · 2020: 103 · 2019: 55
- FWCI
- 106.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endoscopy (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Keywords
- gastric precancerous lesions, chronic atrophic gastritis, intestinal metaplasia, gastric dysplasia, gastric adenocarcinoma risk, chromoendoscopy, virtual chromoendoscopy, endoscopic surveillance, Helicobacter pylori eradication, biopsy targeting, risk stratification, gastric cancer screening
- MeSH terms
- Biopsy, Europe, Gastritis, Atrophic, Humans, Metaplasia, Patient Care Management, Precancerous Conditions, Stomach Neoplasms, Endoscopy, Gastrointestinal, Helicobacter Infections, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. https://app.cochat.ai/papers/10.1055/a-0859-1883
- The paper
- Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., Annibale, B., Dumonceau, J.-M., Barros, R., Fléjou, J.-F., Carneiro, F., van Hooft, J., Kuipers, E., & Dinis-Ribeiro, M. (2019). Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. https://doi.org/10.1055/a-0859-1883
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.